Terry-Ann Burrell

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terry-Ann Burrell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Beam Therapeutics Inc. Chief Financial Officer Common Stock 82,637 $2,523,858 $30.54 26 Apr 2024 Direct
Beam Therapeutics Inc. Chief Financial Officer Stock Option (Right to Buy) 25,000 $610,000 $24.40 26 Apr 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 71,254 $514,098 $7.22 01 Jul 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26,193 03 Jun 2024 Direct

Insider Reports Filed by Terry-Ann Burrell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jul 2024 1 $0 4 Director 03 Jul 2024, 16:39
RAPP Rapport Therapeutics, Inc. 06 Jun 2024 0 $0 3 Director 06 Jun 2024, 18:52
RXRX RECURSION PHARMACEUTICALS, INC. 03 Jun 2024 2 $0 4 Director 05 Jun 2024, 18:12
BEAM Beam Therapeutics Inc. 26 Apr 2024 2 $0 4 Chief Financial Officer 29 Apr 2024, 16:10
BEAM Beam Therapeutics Inc. 01 Apr 2024 1 -$174,926 4 Chief Financial Officer 03 Apr 2024, 19:39
RXRX RECURSION PHARMACEUTICALS, INC. 01 Apr 2024 1 $0 4 Director 03 Apr 2024, 17:42
BEAM Beam Therapeutics Inc. 31 Mar 2024 1 $0 4 Chief Financial Officer 02 Apr 2024, 16:10
BEAM Beam Therapeutics Inc. 31 Jan 2024 1 +$1,342,000 4 Chief Financial Officer 02 Feb 2024, 16:05
RXRX RECURSION PHARMACEUTICALS, INC. 12 Jul 2023 5 -$1,412,414 4 Director 14 Jul 2023, 18:52
RXRX RECURSION PHARMACEUTICALS, INC. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:19
BEAM Beam Therapeutics Inc. 03 Apr 2023 2 -$137,978 4 Chief Financial Officer 05 Apr 2023, 20:30
BEAM Beam Therapeutics Inc. 31 Jan 2023 1 $0 4/A Chief Financial Officer 19 Apr 2023, 16:30
BEAM Beam Therapeutics Inc. 26 Jan 2023 6 -$1,169,875 4 Chief Financial Officer 30 Jan 2023, 15:05
BEAM Beam Therapeutics Inc. 23 Jan 2023 6 -$634,119 4 Chief Financial Officer 25 Jan 2023, 16:25
BEAM Beam Therapeutics Inc. 18 Jan 2023 3 -$1,584,742 4 Chief Financial Officer 20 Jan 2023, 15:18
RXRX RECURSION PHARMACEUTICALS, INC. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:24
RXRX RECURSION PHARMACEUTICALS, INC. 03 Oct 2022 1 $0 4 Director 05 Oct 2022, 21:12
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jul 2022 1 $0 4 Director 06 Jul 2022, 17:48
RXRX RECURSION PHARMACEUTICALS, INC. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 20:12
RXRX RECURSION PHARMACEUTICALS, INC. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 19:23
BEAM Beam Therapeutics Inc. 31 Mar 2022 2 -$105,630 4 CFO 04 Apr 2022, 20:22
BEAM Beam Therapeutics Inc. 31 Jan 2022 1 $0 4 CFO 02 Feb 2022, 17:00
RXRX RECURSION PHARMACEUTICALS, INC. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:41
RXRX RECURSION PHARMACEUTICALS, INC. 01 Oct 2021 1 $0 4 Director 05 Oct 2021, 20:33
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jul 2021 1 $0 4 Director 06 Jul 2021, 17:00
BEAM Beam Therapeutics Inc. 30 Jun 2021 4 -$3,249,600 4 CFO 02 Jul 2021, 18:01
BEAM Beam Therapeutics Inc. 28 Jun 2021 9 -$4,230,416 4 CFO 30 Jun 2021, 18:00